BioCentury
ARTICLE | Company News

C&O Pharmaceutical Technology (Holdings) Ltd., Shionogi deal

October 24, 2011 7:00 AM UTC

Shionogi completed the acquisition of about 42% of C&O, or 277.5 million shares, for S$0.50 per share, or about S$138.8 million ($109.6 million). Shionogi now owns 66% of C&O after acquiring 24% of th...